PL2223121T3 - Sposób różnicowania NZJ i ZJD oraz dalsze rozróżnienie odmian NZJ - Google Patents

Sposób różnicowania NZJ i ZJD oraz dalsze rozróżnienie odmian NZJ

Info

Publication number
PL2223121T3
PL2223121T3 PL07861152T PL07861152T PL2223121T3 PL 2223121 T3 PL2223121 T3 PL 2223121T3 PL 07861152 T PL07861152 T PL 07861152T PL 07861152 T PL07861152 T PL 07861152T PL 2223121 T3 PL2223121 T3 PL 2223121T3
Authority
PL
Poland
Prior art keywords
ibd
ibs
differentiation
kit
disease types
Prior art date
Application number
PL07861152T
Other languages
English (en)
Inventor
Stein Petra Von
Nikolai Kouznetsov
Stein Oliver Von
Alexander Gielen
Original Assignee
Index Diagnostics Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Index Diagnostics Ab Publ filed Critical Index Diagnostics Ab Publ
Publication of PL2223121T3 publication Critical patent/PL2223121T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
PL07861152T 2007-12-20 2007-12-20 Sposób różnicowania NZJ i ZJD oraz dalsze rozróżnienie odmian NZJ PL2223121T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/SE2007/051057 WO2009082298A1 (en) 2007-12-20 2007-12-20 Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd
EP07861152A EP2223121B1 (en) 2007-12-20 2007-12-20 Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd

Publications (1)

Publication Number Publication Date
PL2223121T3 true PL2223121T3 (pl) 2012-12-31

Family

ID=40801429

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07861152T PL2223121T3 (pl) 2007-12-20 2007-12-20 Sposób różnicowania NZJ i ZJD oraz dalsze rozróżnienie odmian NZJ

Country Status (8)

Country Link
US (1) US20110183337A1 (pl)
EP (2) EP2223121B1 (pl)
JP (1) JP2011507509A (pl)
CA (1) CA2747253A1 (pl)
DK (1) DK2223121T3 (pl)
ES (1) ES2391792T3 (pl)
PL (1) PL2223121T3 (pl)
WO (1) WO2009082298A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11693009B2 (en) 2009-02-11 2023-07-04 Cedars-Sinai Medical Center Methods for detecting post-infectious irritable bowel syndrome
WO2011011339A1 (en) * 2009-07-20 2011-01-27 Genentech, Inc. Gene expression markers for crohn's disease
KR102203568B1 (ko) * 2012-09-17 2021-01-15 세다르스-신나이 메디칼 센터 장 및 방광의 운동 장애 및 섬유근육통의 진단 및 치료
EP2713165A1 (en) * 2012-09-28 2014-04-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of vanin-1 as a biomarker of inflammatory bowel diseases
CA2923651C (en) 2013-10-09 2023-03-14 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
EP4043011A1 (en) * 2014-05-16 2022-08-17 Children's Hospital Medical Center Methods for assessing responsiveness to asthma treatment based on vnn-1 expression and promoter methylation
AU2015330872B2 (en) 2014-10-09 2021-04-22 Cedars-Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
CN108350510B (zh) * 2015-09-09 2022-06-03 普梭梅根公司 用于胃肠健康相关病症的源自微生物群系的诊断及治疗方法和系统
IT201600090052A1 (it) * 2016-09-06 2018-03-06 Univ Degli Studi Padova Peptide per la diagnosi differenziale della Malattia di Crohn
AU2018212924A1 (en) 2017-01-30 2019-07-04 Cedars-Sinai Medical Center Diagnosis of scleroderma
CN118421776A (zh) * 2017-03-23 2024-08-02 梅哈里医学院 用于诊断和治疗炎性肠病的方法
WO2019008093A1 (en) * 2017-07-07 2019-01-10 University Of Copenhagen MARKERS FOR DIAGNOSING INFLAMMATORY INTESTINAL DISEASES
WO2020058968A1 (en) * 2018-09-17 2020-03-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Circadian clock gene expression as a diagnostic tool for inflammatory bowel disease (ibd) and for differentiating between ibd and irritable bowel syndrome (ibs)
EP3913371A1 (en) 2020-05-18 2021-11-24 Neuroimmun GmbH Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions
JP2024067304A (ja) * 2022-11-04 2024-05-17 学校法人大阪医科薬科大学 検体中のＶａｎｉｎ－１タンパク質をイムノクロマトグラフィーにより測定する方法、及び検査器具

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830675A (en) 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
US5691151A (en) 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US6033864A (en) * 1996-04-12 2000-03-07 The Regents Of The University Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
US20030036070A1 (en) * 1999-10-21 2003-02-20 Shukti Chakravarti Gene expression profiling of inflammatory bowel disease
JP2003522196A (ja) 2000-02-08 2003-07-22 ユニバーシティー オブ メディシン アンド デンティストリー オブ ニュー ジャージー 潰瘍性大腸炎およびその関連疾患の治療方法および診断方法
FI115139B (fi) 2001-01-10 2005-03-15 Valtion Teknillinen Menetelmä ja testipakkaus solu- tai kudosnäytteissä olevien polynukleotidien määrässä tapahtuvien vaihteluiden kvantitatiiviseen ja/tai vertailevaan arvioimiseen
US6872540B2 (en) 2001-10-26 2005-03-29 Techlab, Inc. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
US20030158254A1 (en) * 2002-01-24 2003-08-21 Xenoport, Inc. Engineering absorption of therapeutic compounds via colonic transporters
EP1534855B1 (en) * 2002-06-25 2010-12-08 Index Diagnostics AB (publ) Method and kit for the diagnosis of ulcerative colitis
DE102004037860A1 (de) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome

Also Published As

Publication number Publication date
US20110183337A1 (en) 2011-07-28
EP2562544A1 (en) 2013-02-27
EP2223121A1 (en) 2010-09-01
WO2009082298A1 (en) 2009-07-02
ES2391792T3 (es) 2012-11-29
EP2223121A4 (en) 2010-12-29
DK2223121T3 (da) 2012-10-22
CA2747253A1 (en) 2009-07-02
EP2223121B1 (en) 2012-07-25
JP2011507509A (ja) 2011-03-10

Similar Documents

Publication Publication Date Title
EP2223121A4 (en) METHOD AND KIT FOR USE IN THE DIFFERENTIATION OF IBD AND IBS AND IN COMPLEMENTARY DISTINCTION BETWEEN DIFFERENT TYPES OF IBD DISEASES
ZA200905886B (en) Methods and kits for administering probiotics
ZA201001789B (en) Composition and methods for use for antibodies against sclerostin
IL202183A0 (en) Anti-notch1 nrr antibodies and methods using same
IL205547A0 (en) Anti-vegf antibody compounds and methods
IL199006A0 (en) Nanoparticulate formulations and methods for the making and use thereof
IL192419A0 (en) Anti-ephb4 antibodies and methods using same
EP2121756A4 (en) ANTIBODIES AND PROCESS FOR THEIR PREPARATION AND USE
ZA200906079B (en) Drug detection kit and method
EP2222871A4 (en) METHODS OF PERFORMING ULTRA-SENSITIVE IMMUNOASSAY
ZA200810460B (en) Modified beta-lactamase and method for its preparation
GB0716070D0 (en) Diagnostic method and kit
EP2185719A4 (en) RANTES ANTIBODIES AND METHOD FOR THEIR USE
IL201613A (en) Cell counting method and kit
GB0802474D0 (en) Mutant proteins and methods for selecting them
IL231891A (en) Anti-ephrinb2 antibodies and methods for their use
IL232011A0 (en) Antibodies to 7egfl and methods of using them
GB0700302D0 (en) Method and kit
TWI370107B (en) Novel methods for making and using halosilylgermanes
GB0603295D0 (en) Methods and kits
EP2083755A4 (en) MEDICAL KIT AND METHOD THEREFOR
GB0803082D0 (en) Method and kit
EP2348865A4 (en) BETA-HYDROXY-GAMMA-AMINOPHOSPHONATES, THEIR METHODS OF PREPARATION AND THEIR USE
ZA200806053B (en) Anti-EphB4 antibodies and methods using same
GB2422145B (en) Kit fitting to an existing storage area and related methods